No headlines found.
No press releases found.
No news found.
Liminatus Pharma - Warrants trades on the stock market under the symbol LIMNW.
As of October 23, 2026, LIMNW stock price was flat at $0.04 with million shares trading.
LIMNW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
LIMNW has underperformed the market in the last year with a price return of -67.5% while the SPY ETF gained +14.3%. LIMNW has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -42.9% and -19.5%, respectively, while the SPY returned +3.2% and -2.4%, respectively.
LIMNW support price is $.03 and resistance is $.05 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LIMNW shares will trade within this expected range on the day.
